BEIJING SUN-NOVO PHARMACEUTICAL RES revenue breakdown overview

BEIJING SUN-NOVO PHARMACEUTICAL RES revenue for the last year amounted to 932.00 M CNY, the most of which — 568.60 M CNY — came from its highest performing source at the moment, Pharmaceutical Research Services, the year earlier bringing 441.90 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought BEIJING SUN-NOVO PHARMACEUTICAL RES 932.12 M CNY, and the year before that — 676.61 M CNY.